APA (7th ed.) Citation

Patricia Garcia-Ortega, Ines Jimenez-Lozano, Álejandro Cruz, Aurora Fernandez Polo, Mercedes Lopez, Gema Ariceta, & Gema Ariceta. (2022). Safety and effectiveness of ferric carboxymaltose intravenous therapy in pediatric patients with chronic kidney disease. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Patricia Garcia-Ortega, Ines Jimenez-Lozano, Álejandro Cruz, Aurora Fernandez Polo, Mercedes Lopez, Gema Ariceta, and Gema Ariceta. Safety and Effectiveness of Ferric Carboxymaltose Intravenous Therapy in Pediatric Patients with Chronic Kidney Disease. Frontiers Media S.A., 2022.

MLA (9th ed.) Citation

Patricia Garcia-Ortega, et al. Safety and Effectiveness of Ferric Carboxymaltose Intravenous Therapy in Pediatric Patients with Chronic Kidney Disease. Frontiers Media S.A., 2022.